TOP STORIES

• BUSINESS Roche/Chugai’s Rozlytrek, AstraZeneca COPD Combos and More Hit Shelves
  September 5, 2019

• BUSINESS Keytruda Boon Aside, MSD Japan Mulls Job Cuts for Sales and Marketing
  September 4, 2019

• BUSINESS Astellas Grabs Global Rights to RIKEN’s aAVC Technology in Oncology
  September 3, 2019

• BUSINESS Astellas Revving Up Digital Transformation Drive, Expands Scope of Data to Derive Values
  September 2, 2019

• TRENDS Sales per Drug Rep Hits Record High in FY2018 as Downsizing Speeds Up
  August 30, 2019

• REGULATORY MHLW Panel Puts a Hold on Possible World’s 1st OK for Ono’s Cancer Cachexia Drug
  August 30, 2019

• ORGANIZATION Japan Doctors’ Group Raps Payer Proposal to Scrap Coverage for Pollen Allergy Drugs
  August 29, 2019

• REGULATORY Rozlytrek, Onpattro and Many More to Join NHI Price List on Sept. 4
  August 28, 2019

• REGULATORY Gene Therapy Collategene Gets 600,000 Yen Price Tag, Peak Sales Put at 1.2 Billion Yen
  August 28, 2019

• REGULATORY Tagrisso to Face 15% Price Cut in November Because It Sold Too Well
  August 27, 2019

• ORGANIZATION Kenporen Proposes Excluding OTC-Like Pollinosis Drugs from Health Coverage, Expecting Annual Savings of 60 Billion Yen
  August 26, 2019

• REGULATORY Japan to Set Up Dedicated Team to Expedite Review of Sakigake-Designated Cell/Gene Therapies
  August 23, 2019

• REGULATORY Tecentriq Wins Japan Nod for SCLC as 1st Checkpoint Drug for This Use
  August 23, 2019

• BUSINESS Price Revision Rates in October Re-Pricing Vary in Crowded DPP-4 Class: Survey
  August 22, 2019

• BUSINESS Frontloaded Price Cuts before Regular April Revision Hurts, Say Drug Makers
  August 21, 2019

• REGULATORY No PMP for Tecentriq, but Prices Rise for All 5 Checkpoint Drugs in Tax Hike Re-Pricing
  August 21, 2019

• BUSINESS Tax Hike Re-Pricing Slams Small Pharma and Gx Players, Impact Milder for Big Firms: Survey
  August 20, 2019

• REGULATORY Kymriah, All Checkpoint Drugs but Tecentriq to Get Price Maintenance Premium in October Re-Pricing
  August 20, 2019

• BUSINESS Sumitomo Dainippon Flip-Plops on Sales Force Cutback as It Ramps Up Diabetes Push
  August 19, 2019

• REGULATORY First “Post-Nesp” Renal Anemia Med Could Land Japan Approval in September
  August 16, 2019

ページ

• « 先頭
• ‹ Prev
• …
• 125
• 126
• 127
• 128
• 129
• 130
• 131
• 132
• 133
• …
• Next ›
• 最終 »